FDA Inspection 917264 — Salix Pharmaceuticals Inc
The FDA completed an inspection of Salix Pharmaceuticals Inc on Mar 9, 2015 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 9, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Raleigh, NC (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)